Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Emmes
Rockville, Maryland, United Statesemmes.com ↗
- Ownership
- Private
- Employees
- ~1525
- Development stage
- Other
01
Overview
Emmes has supported over 2,150 Phase I–IV clinical trials across 90+ countries. It has played key roles in landmark studies such as AREDS/AREDS2 for ophthalmology and major public health initiatives with the NIH. Its expertise spans vaccines/infectious disease, rare disease research including cell/gene therapies, neuroscience, oncology/hematology, maternal/child health. It leverages advanced digital platforms and AI to accelerate trial execution with high quality outcomes
- Therapeutic areas
- Rare DiseasesNeurologyInfectious DiseasesOphthalmologyHematologyOncologyWomen's Health
- Modalities
- Cell therapyGene therapy
- Industry
- Contract Research Organization
02
Partnerships
National Institutes of Health (NIH)Food and Drug Administration (FDA)Department of Defense (DOD)Gates FoundationPATHIAVI15 of the top 25 global biopharma companies
Beyond the preview
Go deeper on Emmes.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Emmes.